RxDoctor Payments Data

Brent Bergen, MD

Pulmonary Disease · Springfield, MONPI 1629070693

Payments from drug & device makers

$600in general payments, 2019–2025

Across 35 payments — averaging $17.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Actelion Pharmaceuticals US, Inc.$114
  • GSK$79
  • Boehringer Ingelheim$63
  • Sunovion Pharmaceuticals Inc.$53
  • CSL Behring$52
  • Genentech USA, Inc.$50
  • plus $191 from 11 others

What the payments were for

  • Food & beverage$54991%
  • Education$529%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$600 in reported general payments places this provider in the 35th percentile of 295 pulmonary disease providers in Missouri.

See all pulmonary disease providers in Missouri

Medicare billing

Part B allowed, 2024
$9,165
Medicare patients
28
Services billed
94

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pulmonary disease in Springfield

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →